EMD MILLIPORE CORPORATION for EMD MILLIPORE CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Discussions related to the inclusion of biotechnology in potential rule to require federal screening of outbound investments
Foreign entity interest: Merck, KGaA, the Foreign Entity listed on the LD-1, has an interest in the matter noted in Section 16.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW TANTILLO | — |
Health Issues HCR
H.R. 2369: Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023; provisions related to diagnostic test regulation
Foreign entity interest: Merck, KGaA, the Foreign Entity listed on the LD-1, has an interest in the matter noted in Section 16.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW TANTILLO | — |
Manufacturing MAN
Discussions related to support for the Industrial Base Expansion program for federal incentives to re-shore manufacturing for the U.S. medical supply chain
Foreign entity interest: Merck, KGaA, the Foreign Entity listed on the LD-1, has an interest in the matter noted in Section 16.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW TANTILLO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.